Vishaka Anil

Vishaka Anil is a Research Associate at Genmab since May 2022, focusing on advancing clinical development of innovative antibody therapeutics for cancer. Previously, Vishaka served as an Associate Scientist at Galapagos from May 2020 to April 2022, where responsibilities included assay development and target discovery. Additional experience includes the development of kidney organoids at MIMETAS and a Master thesis on CRISPR genome editing in anaerobic bacteria at Wageningen University & Research. Early career experience involved a student internship at I&B Seeds Pvt. Ltd., where foundational molecular biology techniques were learned. Vishaka holds a Master of Science in Cellular and Molecular Biotechnology from Wageningen University & Research and a Bachelor of Engineering in Biotechnology from Dayananda Sagar Institutions. Recent education includes a program at Harvard Medical School in mid-2023.